A potential interaction between warfarin and atovaquone

Annals of Pharmacotherapy

Volumn 45, Issue 1, 2011, Pages

  Hidalgo, Kathleen ^a   Lyles, Adraine ^b   Dean, Stacey R ^b  

^a CVS Caremark   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Atovaquone; Displacement; Drug interaction; Pharmacokinetics; Protein binding; Warfarin

Indexed keywords

ANTIVITAMIN K; ATOVAQUONE; ENOXAPARIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MONITORING; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MALE; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTICOAGULANTS; ANTIFUNGAL AGENTS; ATOVAQUONE; DRUG INTERACTIONS; DRUG MONITORING; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS; VITAMIN K; WARFARIN;

EID: 78751482906     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P49     Document Type: Article

References (23)

1. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidencebased clinical practice guidelines (8th ed). Chest 2008;133(6 suppl): 160S-98S. DOI 10.1378/chest.08-0670 (Pubitemid 351892967)
2. Product information. Coumadin (warfarin sodium). Princeton, NJ: Bristol- Myers Squibb, January 2010.
3. Atovaquone. Lexi-Drugs. Hudson, OH: Lexi-Comp. https://online.lexi.com/ crlsql/servlet/crlonline (accessed 2009 Aug 15).
4. Atovaquone and proguanil. Lexi-Drugs. Hudson, OH: Lexi-Comp. https://online.lexi.com/crlsql/servlet/crlonline (accessed 2010 Jul 31).
5. Product information. Mepron (atovaquone). Research Triangle Park, NC: GlaxoSmithKline, May 2008.
6. Sellers EM, Koch-Weser J. Potentiation of warfarin-induced hyproprothrombinemia by chloral hydrate. N Engl J Med 1970;283:827-31. DOI 10.1056/NEJM197010152831601
7. Sellers EM. Plasma protein displacement interactions are rarely of clinical significance. Pharmacology 1979;18:225-7. DOI 10.1159/000137256
8. Harder S, Thürmann P. Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet 1996;30:416-44. DOI 10.2165/00003088-199630060-00002
9. Sands CD, Chan ES, Welty TE. Revisiting the significance of warfarin protein-binding displacement interactions. Ann Pharmacother 2002;36: 1642-4. DOI 10.1345/aph.1A208
10. Knudsen JF, Sokol G. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Pharmacotherapy 2008;28:540-8. DOI 10.1592/phco.28.4.540 (Pubitemid 351466466)
11. Yamreudeewong W, Wong HK, Brausch LM, Pulley KR. Probable interaction between warfarin and marijuana smoking. Ann Pharmacother 2009;43:1347-53. DOI 10.1345/aph.1M064
12. US Food and Drug Administration. MedWatch: the FDA Safety Information and Adverse Event Reporting Program. www.fda.gov/Safety/MedWatch/default.htm (accessed 2010 Jul 20).
13. Sellers EM, Lang M, Koch-Weser J, et al. Enhancement of warfarin-induced hypoprothrombinemia by triclofos. Clin Pharmacol Ther 1972;13: 911-5.
14. Koch-Weser J, Sellers EM. Binding of drugs to serum albumin. New Engl J Med 1976;294:311-6, 526-31. DOI 10.1056/NEJM197602052940605
15. US Food and Drug Administration. Orange book: approved drug products with therapeutic equivalence evaluations. www.accessdata.fda.gov/scripts/cder/ob/ docs/obdetail.cfm?Appl-No=020500&TABLE1=OB-Rx (accessed 2010 Jul 31).
16. Giao PT, de Vries PJ. Pharmacokinetic interactions of antimalarial agents. Clin Pharmacokinet 2001;40:343-73. DOI 10.2165/00003088-200140050-00003
17. Serlin MJ, Mossman S, Sibeon RG, et al. Interaction between diflunisal and warfarin. Clin Pharmacol Ther 1980;28:493-8.
18. MacKichan JJ. Protein binding drug displacement interactions: fact or fiction? Clin Pharmacokinet 1989;16:65-73. DOI 10.2165/00003088-198916020-00001
19. Benet LZ, Hoener B. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 2002;71:115-21. DOI 10.1067/mcp.2002. 121829 (Pubitemid 34271114)
20. Rolan PE. Plasma protein binding displacement interactions-why are they still regarded as clinically important? Br J Clin Pharmacol 1994; 37:125-8.
21. Horn JR, Hansten PD, Chan L-N. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007;41:674-80. DOI 10.1345/aph.1H423 (Pubitemid 46625492)
22. Cavallari LH, Aston JL, Momary KM, et al. Predictors of unstable anticoagulation in African Americans. J Thromb Thrombolysis 2009;27: 430-7. DOI 10.1007/s11239-008-0236-8
23. Anastasi JK, Capili B, Kim G, et al. Symptom management of HIV-related diarrhea by using normal foods: a randomized controlled clinical trial. J Assoc Nurses AIDS Care 2006;17:47-57. DOI 10.1016/j.jana.2006.01.005 (Pubitemid 43562449)